Redcliffe Labs has announced the appointment of Kshitiz Singh as Chief Business Officer – Inorganic Growth, as the company aims to drive strategic expansion through acquisitions, partnerships and network integration.
In this role, Singh will lead the company's mergers and acquisitions strategy, strategic partnerships, and post-acquisition integration initiatives. Working closely with the leadership team, he will focus on identifying high-impact growth opportunities, integrating regional diagnostic businesses into Redcliffe Labs' operating platform, and strengthening the company's diagnostics network across India.
Singh brings over 26 years of leadership experience across diagnostics, healthcare, pharmaceuticals, and FMCG sectors, in roles such as sales leadership, business development and commercial strategy.
Before joining Redcliffe Labs, Singh served as General Manager and Business Head at Agilus Diagnostics, where he played a key role in driving business expansion and strengthening the company's market presence. Earlier, he held leadership positions at organisations such as Piramal Enterprises and Abbott India.
Commenting on the development, Aditya Kandoi, Founder & CEO, Redcliffe Labs said, "The diagnostics industry is entering a phase where scale, integration, and regional reach will define long-term leadership. Across the country, several strong regional diagnostic businesses have built deep clinical expertise and patient trust. We see a significant opportunity to bring these strengths together through an integrated platform that combines technology, clinical excellence, and preventive healthcare. Kshitiz's experience across diagnostics and healthcare will help us accelerate this journey while strengthening our presence across regional markets."
On his appointment, Singh said, “India's diagnostics sector presents a significant opportunity to strengthen healthcare through strategic partnerships and capability building. Redcliffe Labs has built a strong foundation for preventive care driven by its commitment and a clear purpose of adding healthy years to lives. I look forward to working with the leadership to identify the growth opportunities, forge strong partnerships, and strengthen our network to bring trusted, high-quality diagnostics to more people across the country."
